We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+8.95%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$13.8B
AUM Growth
+$1.18B
Cap. Flow
+$317M
Cap. Flow %
2.3%
Top 10 Hldgs %
23.89%
Holding
1,675
New
92
Increased
753
Reduced
716
Closed
103

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$16.8M
2
IBM icon
IBM
IBM
+$10.2M
3
ANSS
Ansys
ANSS
+$8.94M
4
QCOM icon
Qualcomm
QCOM
+$7.56M
5
TSLA icon
Tesla
TSLA
+$6.76M

Sector Composition

Rank Sector Weight
1 Technology 29.82%
2 Consumer Discretionary 8.62%
3 Communication Services 8.47%
4 Healthcare 7.28%
5 Financials 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRGP icon
801
Targa Resources
TRGP
$55.1B
$1.42M 0.01%
8,478
-191
-2% -$31.8K
BCS icon
802
Barclays
BCS
$94.1B
$1.42M 0.01%
68,635
-7,487
-10% -$148K
RVMD icon
803
Revolution Medicines
RVMD
$44B
$1.42M 0.01%
30,373
-3,290
-10% -$129K
DHI icon
804
D.R. Horton
DHI
$42.3B
$1.42M 0.01%
8,365
+4,173
+100% +$656K
RMD icon
805
ResMed
RMD
$30.7B
$1.42M 0.01%
5,174
-11
-0.2% -$3K
RARE icon
806
Ultragenyx Pharmaceutical
RARE
$2.55B
$1.42M 0.01%
47,076
+1,767
+4% +$53K
HAL icon
807
Halliburton
HAL
$26.6B
$1.4M 0.01%
57,069
-5,183
-8% -$115K
TGTX icon
808
TG Therapeutics
TGTX
$7.62B
$1.4M 0.01%
38,748
+2,328
+6% +$76.7K
TDG icon
809
TransDigm Group
TDG
$67.7B
$1.4M 0.01%
1,059
+19
+2% +$27.2K
TLK icon
810
Telkom Indonesia
TLK
$14.9B
$1.39M 0.01%
74,004
+8,191
+12% +$151K
ARWR icon
811
Arrowhead Research
ARWR
$12.4B
$1.39M 0.01%
40,361
-10,457
-21% -$230K
BAX icon
812
Baxter International
BAX
$14.2B
$1.39M 0.01%
61,113
+40,993
+204% +$1.04M
SE icon
813
Sea Limited
SE
$69.5B
$1.39M 0.01%
7,776
+1,371
+21% +$235K
JAZZ icon
814
Jazz Pharmaceuticals
JAZZ
$16.7B
$1.38M 0.01%
10,481
-41
-0.4% -$4.92K
LSCC icon
815
Lattice Semiconductor
LSCC
$18.5B
$1.37M 0.01%
18,642
-1,104
-6% -$67.2K
RNAM
816
DELISTED
Avidity Biosciences
RNAM
$1.37M 0.01%
31,359
-1,243
-4% -$50.2K
PHD
817
DELISTED
Pioneer Floating Rate Fund
PHD
$1.36M 0.01%
136,675
-87,725
-39% -$868K
TTE icon
818
TotalEnergies
TTE
$190B
$1.36M 0.01%
22,754
-908
-4% -$56K
ALV icon
819
Autoliv
ALV
$9B
$1.36M 0.01%
10,991
-89
-0.8% -$10.7K
ENB icon
820
Enbridge
ENB
$112B
$1.33M 0.01%
26,278
-1,707
-6% -$80.3K
SYBT icon
821
Stock Yards Bancorp
SYBT
$2.6B
$1.33M 0.01%
18,938
+629
+3% +$48.6K
KMX icon
822
CarMax
KMX
$8.26B
$1.32M 0.01%
29,336
+19,508
+198% +$1.16M
MDU icon
823
MDU Resources
MDU
$4.32B
$1.31M 0.01%
73,825
+4,939
+7% +$82.4K
FFIV icon
824
F5
FFIV
$22.7B
$1.31M 0.01%
4,060
+380
+10% +$119K
CRS icon
825
Carpenter Technology
CRS
$28.4B
$1.31M 0.01%
5,330
+144
+3% +$36.8K

Similar funds

Guggenheim Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Guggenheim Capital held 1,675 positions worth $13.8B, up 9.4% from $12.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Guggenheim Capital's Q3 2025 filing shows 92 new, 753 increased, 716 reduced and 103 closed positions. Its largest new stake was Thomson Reuters: 100,588 shares worth $15.9M. The largest sale was NVIDIA, an estimated $16.8M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Guggenheim Capital's largest Q3 2025 buy was Thomson Reuters: 100,588 shares worth $15.9M.
  • Guggenheim Capital added most to State Street SPDR S&P 500 ETF Trust in Q3 2025, an estimated $48.1M increase.
  • Guggenheim Capital's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $16.8M.
  • Guggenheim Capital fully exited Ansys in Q3 2025, selling an estimated $8.94M.
  • Guggenheim Capital's ten largest holdings make up 24% of its $13.8B portfolio in Q3 2025.
  • Guggenheim Capital opened 92 new positions and closed 103 in Q3 2025.
  • Guggenheim Capital's portfolio value rose 9.4% quarter-over-quarter to $13.8B.

Based on Guggenheim Capital's 13F filing for Q3 2025, filed 13 Nov 2025.